Actively Recruiting
Recovery From ICUAW Following Severe Respiratory and Cardiac Failure
Led by Barts & The London NHS Trust · Updated on 2026-01-07
100
Participants Needed
1
Research Sites
389 weeks
Total Duration
On this page
Sponsors
B
Barts & The London NHS Trust
Lead Sponsor
Q
Queen Mary University of London
Collaborating Sponsor
AI-Summary
What this Trial Is About
To observe and identify determinants of recovery from intensive care unit-acquired weakness (ICUAW) following a severe cardiorespiratory failure requiring extra-corporeal membrane oxygenation (ECMO). Additionally, to discover the effects of ICUAW on physical function and health-related quality of life (HRQoL) after critical illness. CLEVERER is a clinical observational pilot study.
CONDITIONS
Official Title
Recovery From ICUAW Following Severe Respiratory and Cardiac Failure
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Above the age of 18
- Adults with severe cardio-respiratory failure requiring ECMO
- Adults with personal and professional consultee agreement to enroll in the trial
You will not qualify if you...
- Previous stroke
- Neuromuscular disease
- Malignancy
- Underlying neuromuscular disease
- Pediatrics
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
St Bartholomew's hospital (Barts NHS trust)
London, United Kingdom, EC1A 7BE
Actively Recruiting
Research Team
M
Mark Griffiths, PhD FRCP
CONTACT
A
Ashley Thomas, MSc
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here